ArticleMolecular therapy. Nucleic acids2025

mRNA vaccine based on high-frequency prevalent antigens provides broad protection against influenza B virus.

Ziqi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.